Status:
COMPLETED
Endoprosthesis Treatment Effects on Human Abdominal Aorta Aneurysms (AAA) Metabolic Activity
Lead Sponsor:
Central Hospital, Nancy, France
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Abdominal Aortic Aneurysm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether Positron Emission Tomography imaging can help to predict the evolutivity of AAA treated with endovascular prosthesis.
Detailed Description
Background: Abdominal Aorta Aneurysm(AAA) is a frequently occurring atherothrombotic disease, linked to male gender and aging. Due to the current aging of the population, the incidence of rupture may...
Eligibility Criteria
Inclusion
- Large AAA scheduled for endovascular surgery within one month
- Written informed consent
Exclusion
- Evolutive neoplasm
- Chronic liver disease
- Connective tissue diseases: rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, Crohn's disease, polymyositis/dermatomyositis, mixed connective tissue disease
- Crohn's disease
- Evolutive tuberculosis
- Contraindication to CT scan
- Pregnancy and breastfeeding
- Women of child bearing potential
- Patient unable to understand the study aims
- Patient unable to comply with scheduled visit
- Participation in other investigational studies.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT01253252
Start Date
August 1 2009
Last Update
July 28 2017
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Le Bocage - Dijon's Hospital
Dijon, France, 21 000
2
Cardiologic Hospital
Lille, France, 59037
3
Brabois Hospital
Nancy, France, 54500
4
Institut du Thorax, Nantes's Hospital
Nantes, France, 44 093